Evidence map›Paper›PMID 38645731›Full record

ArticleFrontiers in biophysics2024

Utilizing surface plasmon resonance as a novel method for monitoring

Phuong H Nguyen, Shuolin Cui, Amanda M Kozarich, Alex Rautio, Arthur G Roberts, May P Xiong

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in biophysics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Phuong H NguyenDepartment of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, GA, United States.
Shuolin CuiDepartment of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, GA, United States.
Amanda M KozarichDepartment of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, GA, United States.
Alex RautioDepartment of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, GA, United States.
Arthur G RobertsDepartment of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, GA, United States.
May P XiongDepartment of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, GA, United States.
University of Georgia · US

Funding

Overcoming Cancer Resistance Mediated by the Human MDR1 TransporterR01CA204846 · NCI · UNIVERSITY OF GEORGIA · PI ROBERTS, ARTHUR G · 2017 to 2021
$1.9M
LipoGels for Chelation of Transfusional Iron-OverloadR01DK099596 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI XIONG, M PANG · 2013 to 2017
$1.5M
NCI NIH HHS R01 CA204846NIDDK NIH HHS R01 DK099596
6 · The paper itself

Abstract

P-glycoprotein (Pgp) is known for its dichotomous roles as both a safeguarding efflux transporter against xenobiotics and as a catalyst for multidrug resistance. Given the susceptibility of numerous therapeutic compounds to Pgp-mediated resistance, compliance with Food and Drug Administration (FDA) guidelines mandates an in-depth

Indexed as

efflux analysisefflux kineticsp-glycoproteinsurface plasmon resonacetransport assay

Identifiers

PMID38645731
PMCPMC11027885
OpenAlexW4392584019

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.